Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Arkansas Epilepsy Program (AEP) is a private comprehensive epilepsy clinic and clinical research center located in Little Rock, Arkansas. Founded in 1994 by Dr. Victor Biton, the program is one of the state's most established facilities for the specialized diagnosis and management of seizure disorders. AEP provides a full suite of diagnostic services, including in-house and ambulatory video-EEG monitoring, and offers treatments ranging from pharmacological management to the programming of neurostimulation devices like Vagus Nerve Stimulation (VNS). The center is also a significant contributor to the field of epilepsy research, serving as a site for numerous Phase II-IV clinical trials evaluating next-generation antiepileptic medications and therapeutic devices. Through its multidisciplinary team, the program aims to improve the quality of life for patients with refractory epilepsy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Arkansas Epilepsy Program.